Source: Annual Congress 2011 - Monitoring with lung function tests in airway diseases
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
S. J. Lee, S. N. Lee, M. K. Lee, K. C. Shin, S. J. Yong, S. H. Kim, W. Y. Lee (Wonju, Republic Of Korea). A negative result of airway reversibility test in obstructive airway disease does not mean no reserve of lung function. Eur Respir J 2011; 38: Suppl. 55, 916

Member's Comments

No comment yet.

Related content which might interest you: Which respiratory function test for which lung disease Source: Annual Congress 2005 - Lung function measurements and predicted values from infants to 100-year-old adults Year: 2005 The bronchodilator test in patients with chronic airway obstruction: the responsiveness of lung function parameters Source: International Congress 2018 – Respiratory physiology and measurements Year: 2018 Small airway dysfunction and flow and volume bronchodilator responsiveness in patients with chronic obstructive pulmonary disease Source: International Congress 2015 – Monitoring and phenotyping COPD Year: 2015 Airway inflammation in COPD: physiological outcome measures and induced sputum Source: Eur Respir J 2003; 21: 19S-28S Year: 2003 Defining airways obstruction – fixed ratio versus lower limit of normal Source: Annual Congress 2007 - Management of COPD: pushing forward the boundaries in primary care Year: 2007 Increased airway resistance in asthma and emphysema and its relation to other pulmonary function tests Source: Eur Respir J 2007; 30: Suppl. 51, 618s Year: 2007 Bacterial load in chronic obstructive pulmonary disease and its relationship with airway inflammation and lung function Source: Annual Congress 2011 - Role of infection in exacerbations of COPD Year: 2011 Forced inspiratory volume in one second (FIV1) in the assessment of reversibility of airway obstruction in patients with chronic obstructive pulmonary disease (COPD) and in relation to the severity Source: Eur Respir J 2002; 20: Suppl. 38, 300s Year: 2002 Is residual volume reversibility a better marker than FEV1 reversibility in diagnosing reversible airway disease  in asthma? Source: International Congress 2017 – Monitoring novel biomarkers in asthma Year: 2017 FEV1 is not sufficient for assessing bronchodilator reversibility in chronic obstructive pulmonary disease Source: Eur Respir J 2004; 24: Suppl. 48, 121s Year: 2004 Bronchodilator-induced changes in dynamic hyperinflation but not in airway obstruction are associated with improvement in dyspnoea in patients with chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2001; 18: Suppl. 33, 174s Year: 2001 Relationship of airway dimensions with airflow limitation or lung volumes in chronic obstructive pulmonary disease (COPD) Source: Eur Respir Rev 2006; 15: 197-199 Year: 2006 Use of continuous positive airway pressure reduces airway reactivity in adults with asthma Source: Eur Respir J 2013; 41: 317-322 Year: 2013 Evaluation of bronchodilator responses in patients with "irreversible" emphysema Source: Eur Respir J 2001; 18: 914-920 Year: 2001 Variability and effects of bronchial colonization on symptoms and lung function in moderate COPD Source: Annual Congress 2006 - Clinical aspects and treatment of lower respiratory infection in COPD patients Year: 2006 Modified test to identify the reversibility of bronchial obstruction in patients with chronic obstructive pulmonary disease Source: International Congress 2018 – Respiratory physiology and measurements Year: 2018 Airway obstruction reversibility test in the assessment of COPD severity Source: Eur Respir J 2005; 26: Suppl. 49, 57s Year: 2005 Decreasing of lung function in patients with chronically obstructive lung diseases as effect of damage of bronchial mucosa cilia Source: Eur Respir J 2003; 22: Suppl. 45, 416s Year: 2003 Impulse oscillation respiratory reactance and airway reversibility in chronic obstructive pulmonary disease Source: International Congress 2015 – Monitoring and phenotyping COPD Year: 2015